THE KAYLEFF YAK

Rakkab starts investing on Research and Development. From 1965 to 1996, the Government's Department of Research, Technology & Application received between 3-5% of Rakkab's annual budget.

The Kingdom of Jeramia granted independence of all its colonies

• February 1996: Rakkab's Parliament adopted legislation to privatize the Department;
• April 1996: Privatization of DORTA was effective;
• May 1996: DORTA's shares began on the NYSE.

During his hospital practice (1998 - 2000), Dr. Bello observed that the incidence of diabetes and obesity was lower in Aurok than in Rakkab

Dr. Bello spent a year living in rural Aurok, doing fieldwork and investigating Aurokan dietary and cultural practices.

Dr. Bello concluded that the discrepancy was correlated with a never-before-identified enzyme found in the gallbladder of the Yak, a key ingredient in Tirhinga Nos Lustuk. He published his findings.

Dr. Bello isolated the Lustuk Enzyme and used it to produce an experimental medication. During the course of 2 years of testing, the drug was proved as highly effective.

The medication was named "Gallvectra". According to Rakkabi law, patents are published and are open to complaints, for a period of 18 months. Patent duration: 20 years.

March: Aurokan Minister wrote to his Rakkabi counterpart, saying that the health benefits of the Yak's enzyme gallbladders were long-known use by the Aurokan people.
April: DORTA's attorneys replied, saying that the isolation of the Lustuk Enzyme and its discovery as a medical treatment of insulin-resistant diseases was the real invent.